Contact Us

Yes. SLCO1A2 rescue experiments require attention to transporter topology: • Construct design: use a codon-modified SLCO1A2 sequence with a small C-terminal tag (FLAG, HA). SLCO1A2 has the canonical OATP 12-transmembrane architecture. • Surface expression validation: confirm plasma membrane localization before transport assays. • Polymorphism rescue: clinically relevant SLCO1A2 variants (e.g., R168C) can be introduced for pharmacogenomic studies in a controlled background. • Functional readout: rescue should restore cellular uptake of canonical OATP1A2 substrates (BSP, T3/T4, methotrexate) measured by appropriate detection methods. Huh-7 transduces efficiently with lentivirus and supports stable rescue line generation.

Yes. TAOK2 rescue experiments require attention to isoform specificity and disease variant analysis: • Construct design: use codon-modified TAOK2 sequences for the relevant isoform (TAOK2α vs TAOK2β have different C-termini and subcellular localizations). C-terminal tags (FLAG, HA) are preferred. • Kinase-dead rescue: an active site mutation abolishes kinase activity and is the standard specificity control. • Autism-associated mutant rescue: 16p11.2-associated TAOK2 variants can be introduced for genotype-function correlation in a controlled background. • Functional readout: rescue should restore p38/JNK activation following stress stimulation. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying STK38L's role as a Hippo pathway-related NDR kinase or its functions in centrosome regulation, cell cycle, and immune cell biology. The Knockout line is appropriate for asking whether STK38L is required for substrate phosphorylation in contexts where its STK38 (NDR1) paralog may not fully compensate. Overexpression is useful for testing whether elevated STK38L activity drives specific phenotypes or for studying its hippo-related signaling contributions. Important consideration: STK38 (NDR1) and STK38L (NDR2) share substantial functional overlap as NDR family kinases. Single STK38L knockout in HAP1 may show mild phenotypes if STK38 compensates. The EDITGENE Knockout is most informative when combined with the parallel STK38 knockout (also available) for family-specific dissection. Rescue with wild-type or kinase-dead STK38L is the standard control.

Yes. STK38L rescue experiments require attention to NDR activation requirements: • Construct design: use a codon-modified STK38L sequence with a small C-terminal tag (FLAG, HA). The N-terminal regulatory region (NTR) interacts with MOB1 activators and must be preserved. • Kinase-dead rescue: an active site mutation (typically K117A or D203A in the catalytic loop) abolishes catalytic activity and is the standard specificity control. • MOB1-binding-deficient rescue: NTR mutations that disrupt MOB1 binding test the dependence of phenotypes on NDR kinase activation rather than basal activity. • Paralog rescue panel: rescue with STK38L in STK38 knockouts (or combined-knockout backgrounds) enables family-specific function dissection. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying STK38's role in Hippo pathway-related signaling, centrosome duplication regulation, or apoptosis modulation. The Knockout line is the standard tool for asking whether STK38 (NDR1) is required for these processes — STK38 has been implicated in MOB1-mediated activation downstream of Hippo signaling. Overexpression is useful for testing sufficiency for substrate phosphorylation or for studying STK38's contribution to cancer biology contexts. For STK38 research, the EDITGENE Knockout in HAP1 is the more rigorous tool, though STK38L paralog compensation should be considered. Combined analysis with the parallel STK38L knockout (also available from EDITGENE) enables NDR family-specific dissection. Rescue with wild-type or kinase-dead STK38 is essential, particularly for studies of NDR kinase inhibitor specificity.

Yes. STK38 rescue experiments require attention to NDR family activation: • Construct design: use a codon-modified STK38 sequence with a small C-terminal tag (FLAG, HA). The N-terminal regulatory region and kinase domain are both essential. • Kinase-dead rescue: an active site mutation (K117A or D200A) serves as the catalytic activity specificity control. • MOB1-binding-deficient rescue: NTR mutations that disrupt MOB1 binding distinguish activated kinase functions from basal kinase activity. • Inhibitor specificity studies: NDR family inhibitors often show cross-reactivity — rescue with STK38 wild-type versus kinase-dead enables on-target validation. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying TAB2's role as a TAK1 adapter in IL-1/TNF/TLR signaling, or its functions in NF-κB pathway activation. The Knockout line is the standard tool for both — TAB2 binds K63-linked polyubiquitin chains and recruits TAK1 to signaling complexes, making it essential for cytokine-induced NF-κB activation. Overexpression is useful for testing TAB2's sufficiency in pathway activation or for studying its competition with TAB3 paralog. For innate immune signaling research, the EDITGENE TAB2 Knockout in HAP1 is informative for dissecting K63-ubiquitin-dependent signaling, though TAB3 paralog compensation should be considered when interpreting phenotypes. Rescue with wild-type or ubiquitin-binding-deficient (NZF domain mutant) TAB2 separates ubiquitin-sensing from adapter functions.

Yes. TAB2 rescue experiments require attention to its ubiquitin-binding and adapter functions: • Construct design: use a codon-modified TAB2 sequence with a small C-terminal tag (FLAG, HA). The C-terminal NZF (nuclear protein localization 4-type zinc finger) domain mediates K63-ubiquitin chain binding and must be preserved. • NZF mutant rescue: specific NZF domain mutations (e.g., T674A) abolish K63-polyubiquitin binding without disrupting TAK1 interaction — the gold standard for separating ubiquitin-sensing from adapter functions. • Paralog considerations: TAB3 expression analysis helps interpret single TAB2 rescue, given their overlapping roles in TAK1 complex assembly. • Functional readout: rescue should restore IL-1β-, TNF-α-, and TLR-induced NF-κB activation and TAK1 phosphorylation patterns. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying STAMBP's role as an endosomal-associated K63-deubiquitinase or modeling microcephaly-capillary malformation syndrome (MIC-CAP). The Knockout line is the standard tool for both — STAMBP deubiquitinates ESCRT-pathway substrates and its loss-of-function causes MIC-CAP syndrome. Overexpression is useful for testing whether elevated STAMBP enhances K63-chain hydrolysis or for studying disease-associated catalytic variants. For STAMBP research, the EDITGENE Knockout in HAP1 provides a clean background for mechanistic dissection of K63-ubiquitin-dependent endosomal signaling. Rescue with wild-type or catalytically-dead (E292A in the JAMM motif) STAMBP is the standard specificity control. Disease-associated MIC-CAP mutations enable disease modeling.

Yes. STAMBP rescue experiments are well-established given the maturity of K63-DUB research: • Construct design: use a codon-modified STAMBP sequence with a small N- or C-terminal tag (FLAG, HA). The N-terminal MIT domain (microtubule interacting and trafficking) binds ESCRT components and must be preserved. • Catalytically-dead rescue: the E292A mutation in the JAMM motif abolishes K63-deubiquitinase activity and is the standard specificity control. • MIC-CAP disease mutation rescue: patient-derived STAMBP mutations enable genotype-phenotype correlation studies for microcephaly-capillary malformation syndrome. • Functional readout: rescue should restore K63-chain hydrolysis on endosomal substrates and normal EGFR sorting kinetics through the ESCRT pathway. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying SMARCC1 (BAF155)'s role as a core BAF complex subunit or its specific contributions to chromatin remodeling stability. The Knockout line is appropriate for asking whether SMARCC1 is required for BAF complex assembly — SMARCC1 is a core component shared between canonical BAF and PBAF complexes. Overexpression is useful for testing whether elevated SMARCC1 alters complex stoichiometry. Important consideration: SMARCC1 and SMARCC2 (BAF170) are paralogs with partial functional overlap — single SMARCC1 knockout may show effects modulated by SMARCC2 expression levels. The EDITGENE Knockout in HAP1 provides a clean genetic background for studying SMARCC1-specific functions and BAF complex biology. Rescue with wild-type or domain-deletion SMARCC1 enables structure-function dissection.

Yes. SMARCC1 rescue experiments require attention to BAF complex core architecture: • Construct design: use a codon-modified SMARCC1 sequence with a C-terminal tag (FLAG, HA). SMARCC1 contains SANT and SWIRM domains that mediate protein interactions within the BAF complex. • Domain-deletion rescue: separate rescue with SANT or SWIRM domain deletions dissects domain-specific contributions to complex assembly. • Paralog considerations: SMARCC2 (BAF170) expression analysis aids interpretation of SMARCC1-specific rescue effects. • Functional readout: rescue should restore BAF complex integrity and chromatin accessibility at SMARCC1-dependent loci. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying SNAP-25's role in neuronal SNARE-mediated vesicle fusion or in non-neuronal exocytosis contexts. The Knockout line in N1E-115 is appropriate for asking whether SNAP-25 is required for regulated neurotransmitter release and synaptic vesicle exocytosis in a neuronal cell context. Overexpression is useful for testing isoform-specific functions (SNAP-25a vs SNAP-25b) or for studying SNAP-25 mutations in encephalopathy models. For neuronal SNARE biology research, the EDITGENE SNAP-25 Knockout in N1E-115 provides a neuronal-relevant background — N1E-115 is a murine neuroblastoma line that has long served as a neurosecretion model. Rescue with wild-type, BoNT/A/E-resistant (cleavage site mutant), or disease-associated mutant SNAP-25 enables mechanistic studies of SNARE function and botulinum toxin specificity.

Yes. SNAP-25 rescue experiments require attention to SNARE motif function and isoform selection: • Construct design: use a codon-modified Snap25 sequence with a small internal or C-terminal tag (small FLAG/HA only; large tags disrupt SNARE assembly). SNAP-25 has two SNARE motifs and a central palmitoylated linker that anchors the protein to membranes. • Isoform-specific rescue: SNAP-25a versus SNAP-25b isoforms have different developmental expression patterns and exocytic properties. • Cleavage-resistant variants: BoNT/A cleaves SNAP-25 at Q197-R198, BoNT/E at R180-I181. Resistant point mutations enable specificity studies of botulinum neurotoxins. • Functional readout: rescue should restore depolarization-induced exocytosis and SNARE complex formation in N1E-115 neuronal context. N1E-115 is a mouse neuroblastoma cell line that transduces with lentivirus at moderate efficiency; differentiation conditions (serum reduction, DMSO) may be required for neurosecretion phenotyping.

The choice depends on whether you are studying SLC60A2 (MFSD4B)'s role as a sodium-dependent hexose transporter or its emerging functions in urea transport in the renal inner medulla. Note that SLC60A2 is the current HGNC-approved symbol; this gene is also widely referred to as MFSD4B in published literature and has been characterized as a sodium-dependent glucose and fructose transporter (Horiba et al., 2003), with more recent evidence suggesting a potential role as a urea channel. The Knockout line is appropriate for asking whether SLC60A2 is required for these transport activities, with the caveat that its principal physiological site is the renal inner medulla rather than colorectal tissue. Overexpression is useful for transport activity characterization in heterologous systems — HCT 116 background, while a colorectal cancer line, can serve as a tractable expression context. For SLC60A2 research, the EDITGENE Knockout in HCT 116 is most informative for biochemical and inhibitor specificity studies; physiologically relevant function research (renal fructose/urea handling, kidney medulla biology) requires kidney-derived models. Rescue with wild-type or transport-deficient SLC60A2 enables structure-function studies and substrate specificity characterization.